Positron Emission Tomography (PET) Study With [11C]AZD2995 and [11C]AZD2184, Candidate PET Ligands for β Amyloid
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The study is carried out in order to investigate if [11C]AZD2995, compared to [11C]AZD2184,
is a more suitable PET ligand for in vivo imaging of β amyloid depositions in the human
brain. In the study the two PET ligands will be examined in both healthy volunteers and
patients with Alzheimer's Disease.